The Journal of Pediatrics
Volume 155, Issue 5 , Pages 721-727 , November 2009

An 8-Year Follow-up Study of Profiles and Predictors of Methylphenidate Use in a Nationwide Sample of Boys

  • Elisa Romano, PhD

      Affiliations

    • School of Psychology, University of Ottawa, Ottawa, Canada
    • Corresponding Author InformationReprint requests: Dr Elisa Romano, School of Psychology, University of Ottawa, 200 Lees Avenue, Ottawa, Ontario, Canada, K1N 6N5.
    • ,
  • Stacey Thornhill, BA

      Affiliations

    • Faculty of Education, University of Ottawa, Ottawa, Canada
    • ,
  • Éric Lacourse, PhD

      Affiliations

    • Department of Sociology, University of Montreal, Montreal, Canada

Received 15 August 2008 ,Revised 16 April 2009 ,Accepted 18 May 2009.

References 

  1. Egger HL, Angold A. Common emotional and behavioral disorders in preschool children: Presentation, nosology, and epidemiology. J Child Psychol Psychiatry. 2006;47:313–337
  2. Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin N Am. 2000;9:544–555
  3. Charach A, Cao H, Schachar R, To T. Correlates of methylphenidate use in Canadian children: a cross-sectional study. Can J Psychiatry. 2006;51:17–26
  4. Romano E, Baillargeon RH, Wu HX, Robaey P, Tremblay RE. Prevalence of methylphenidate use and change over a two-year period: a nationwide study of 2- to 11-year old Canadian children. J Pediatr. 2002;141:71–75
  5. Miller AR, Lalonde CE, McGrail KM, Armstrong RW. Prescription of methylphenidate to children and youth, 1990-1996. CMAJ. 2001;165:1489–1494
  6. Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000;283:1025–1030
  7. Zito JM, Safer DJ, dosReis S, Gardner JF, Magder L, Soeken K, et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med. 2003;157:17–25
  8. Olfson M, Marcus SC, Weissman MM, Jensen PS. National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry. 2002;41:514–521
  9. Winterstein AG, Gerhard T, Shuster J, Zito JM, Johnson M, Liu H, et al. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Ann Pharmacother. 2008;42:24–31
  10. Zuvekas SH, Vitiello B, Norquist GS. Recent trends in stimulant medication use among US children. Am J Psychiatry. 2006;163:579–585
  11. Berbatis CG, Sunderland VB, Bulsara M. Licit psychostimulant consumption in Australia, 1984-2000: international and jurisdictional comparison. 2002;177:539-543.
  12. Knellwolf A-L, Deligne J, Chiarotti F, Auleley G-R, Palmieri S, Boisgard CB, et al. Prevalence and patterns of methylphenidate use in French children and adolescents. Eur J Clin Pharmacol. 2008;64:311–317
  13. Vinker S, Vinker R, Elhayany A. Prevalence of methylphenidate use among Israeli children 1998-2004. Clin Drug Invest. 2006;26:161–167
  14. Romano E, Baillargeon RH, Fortier I, Wu HX, Robaey P, Zoccolillo M, et al. Individual change in methylphenidate use in a national sample of children aged 2 to 11 years. Can J Psychiatry. 2005;50:144–152
  15. Miller AR, Lalonde CE, McGrail KM. Children's persistence with methylphenidate therapy: a population-based study. Can J Psychiatry. 2004;49:761–768
  16. Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant medication in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2001;40:922–928
  17. Barkley R, Fischer M, Edelbrock C, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria, I: an 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1990;29:546–557
  18. Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A, et al. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1996;35:343–351
  19. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007;161:857–864
  20. Olfson M, Gameroff MJ, Marcus SC, Jensen PS. National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry. 2003;160:1071–1077
  21. Brownell MD, Mayer T, Chateau D. The incidence of methylphenidate use by Canadian children: What is the impact of socioeconomic status and urban/rural residence?. Can J Psychiatry. 2006;51:847–854
  22. Angold A, Erkanli A, Egger HL, Costello EJ. Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry. 2000;39:975–984
  23. Sawyer MG, Rey JM, Graetz BW, Clark JJ, Baghurst PA. Use of medication by young people with attention-deficit/hyperactivity disorder. Med J Aust. 2002;177:21–25
  24. Miller AR, Kohen D, Johnston C. Child characteristics and receipt of stimulant medications: a population-based study. Ambul Pediatr. 2008;8:175–181
  25. Statistics Canada and Human Resources Development Canada. National Longitudinal Survey of Children and Youth. Overview of survey instruments for 1994-1995 data collection cycle 1. Ottawa, ON: Statistics Canada and Human Resources Development Canada; 1995;
  26. Statistics Canada and Human Resources Development Canada. National Longitudinal Survey of Children and Youth. Overview of survey instruments for 1996-1997 data collection cycle 2. Ottawa, ON: Statistics Canada and Human Resources Development Canada; 1997;
  27. Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001;22:60–73
  28. Achenbach TM, Edelbrock CS. Behavioral problems and competencies reported by parents of normal and disturbed children aged four through sixteen. Monogr Soc Res Child Dev. 1981;(1):46;Serial No. 188
  29. Offord D, Boyle MH, Fleming JE, Blum HM, Grant NI. Ontario Child Health Study: summary of selected results. Can J Psychiatry. 1989;34:483–491
  30. Tremblay RE, Pihl RO, Vitaro F, Dobkin PL. Predicting early onset of male antisocial behavior from preschool behavior. Arch Gen Psychiatry. 1994;51:732–739
  31. Nagin D. Analyzing developmental trajectories: a semi-parametric, group-based approach. Psychol Methods. 1999;4:139–157
  32. Nagin D, Tremblay RE. Trajectories of boys' physical aggression, opposition, and hyperactivity on the path to physically violent and nonviolent juvenile delinquency. Child Dev. 1999;70:1181–1196
  33. Nagin D, Tremblay RE. Parental and early childhood predictors of persistent physical aggression in boys from kindergarten to high school. Arch Gen Psychiatry. 2001;58:389–394
  34. Visser SN, Lesesne CA, Perou R. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Pediatrics. 2007;119:S99–S106
  35. Lancaster BP. Defining and interpreting suppressor effects: Advantages and limitations. Paper presented at the Annual Meeting of the Southwest Educational Research Association 1999.

 Presented as a poster at the annual convention of the Canadian Psychological Association in Calgary, Alberta, Canada, June 8 to 10, 2006, and supported in part by a grant from the Social Sciences and Humanities Research Council of Canada – Initiatives on the New Economy: Raising and Leveling the Bar (#512-2003-1016, E.R. and É.L.). The authors declare no conflicts of interest.

PII: S0022-3476(09)00507-1

doi: 10.1016/j.jpeds.2009.05.028

The Journal of Pediatrics
Volume 155, Issue 5 , Pages 721-727 , November 2009

Article Tools

* Image Usage & Resolution